These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 23102915)

  • 1. The role of non-coding RNAs in diabetic nephropathy: potential applications as biomarkers for disease development and progression.
    Alvarez ML; Distefano JK
    Diabetes Res Clin Pract; 2013 Jan; 99(1):1-11. PubMed ID: 23102915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Where are we in diabetic nephropathy: microRNAs and biomarkers?
    McClelland A; Hagiwara S; Kantharidis P
    Curr Opin Nephrol Hypertens; 2014 Jan; 23(1):80-6. PubMed ID: 24247820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers for early diagnosis of type 2 diabetic nephropathy: a study based on an integrated biomarker system.
    Huang M; Liang Q; Li P; Xia J; Wang Y; Hu P; Jiang Z; He Y; Pang L; Han L; Wang Y; Luo G
    Mol Biosyst; 2013 Aug; 9(8):2134-41. PubMed ID: 23719966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Novel biomarkers for diabetic nephropathy].
    Araki S
    Rinsho Byori; 2014 Feb; 62(2):171-9. PubMed ID: 24800493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pathogenesis of diabetic nephropathy: focus on microRNAs and proteomics.
    Conserva F; Pontrelli P; Accetturo M; Gesualdo L
    J Nephrol; 2013; 26(5):811-20. PubMed ID: 23543479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Markers of and risk factors for the development and progression of diabetic kidney disease.
    Macisaac RJ; Ekinci EI; Jerums G
    Am J Kidney Dis; 2014 Feb; 63(2 Suppl 2):S39-62. PubMed ID: 24461729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review: The role of microRNAs in kidney disease.
    Li JY; Yong TY; Michael MZ; Gleadle JM
    Nephrology (Carlton); 2010 Sep; 15(6):599-608. PubMed ID: 20883280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the potassium channel KCa3.1 in diabetic nephropathy.
    Huang C; Pollock CA; Chen XM
    Clin Sci (Lond); 2014 Oct; 127(7):423-33. PubMed ID: 24963668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noncoding RNAs in Diabetic Nephropathy: Pathogenesis, Biomarkers, and Therapy.
    Lv J; Wu Y; Mai Y; Bu S
    J Diabetes Res; 2020; 2020():3960857. PubMed ID: 32656264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy.
    Elmarakby AA; Sullivan JC
    Cardiovasc Ther; 2012 Feb; 30(1):49-59. PubMed ID: 20718759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA biomarkers in clinical renal disease: from diabetic nephropathy renal transplantation and beyond.
    Nassirpour R; Raj D; Townsend R; Argyropoulos C
    Food Chem Toxicol; 2016 Dec; 98(Pt A):73-88. PubMed ID: 26925770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. microRNA in the development of diabetic complications.
    McClelland AD; Kantharidis P
    Clin Sci (Lond); 2014 Jan; 126(2):95-110. PubMed ID: 24059587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of diabetic nephropathy--old buddies and newcomers part 2.
    Nawroth PP; Isermann B
    Exp Clin Endocrinol Diabetes; 2010 Nov; 118(10):667-72. PubMed ID: 20658437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocannabinoids and the renal proximal tubule: an emerging role in diabetic nephropathy.
    Jenkin KA; Verty AN; McAinch AJ; Hryciw DH
    Int J Biochem Cell Biol; 2012 Nov; 44(11):2028-31. PubMed ID: 22842535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diabetic nephropathy. A historical, clinical and diagnostic framework].
    Conti AA
    Minerva Med; 2002 Oct; 93(5):347-55. PubMed ID: 12410167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circular RNAs; powerful microRNA sponges to overcome diabetic nephropathy.
    Mafi A; Yadegar N; Salami M; Salami R; Vakili O; Aghadavod E
    Pathol Res Pract; 2021 Nov; 227():153618. PubMed ID: 34649056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging roles for miRNAs in the development, diagnosis, and treatment of diabetic nephropathy.
    DiStefano JK; Taila M; Alvarez ML
    Curr Diab Rep; 2013 Aug; 13(4):582-91. PubMed ID: 23666892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Podocyte hypertrophy in diabetic nephropathy.
    Kim NH
    Nephrology (Carlton); 2005 Oct; 10 Suppl():S14-6. PubMed ID: 16174280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights into the use of biomarkers of diabetic nephropathy.
    Jha JC; Jandeleit-Dahm KA; Cooper ME
    Adv Chronic Kidney Dis; 2014 May; 21(3):318-26. PubMed ID: 24780461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.